469 related articles for article (PubMed ID: 22345684)
1. Differences in the use of guideline-recommended therapies among 14 European countries in patients with acute coronary syndromes undergoing PCI.
Zeymer U; James S; Berkenboom G; Mohacsi A; Iñiguez A; Coufal Z; Sartral M; Paget MA; Norrbacka K; Ferrieres J; Bakhai A;
Eur J Prev Cardiol; 2013 Apr; 20(2):218-28. PubMed ID: 22345684
[TBL] [Abstract][Full Text] [Related]
2. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
[TBL] [Abstract][Full Text] [Related]
3. Predictors, cost, and outcomes of patients with acute coronary syndrome who receive optimal secondary prevention therapy: results from the antiplatelet treatment observational registries (APTOR).
Zeymer U; Berkenboom G; Coufal Z; Belger M; Sartral M; Norrbacka K; Bakhai A;
Int J Cardiol; 2013 Dec; 170(2):239-45. PubMed ID: 24225199
[TBL] [Abstract][Full Text] [Related]
4. A prospective observational study of treatment practice patterns in acute coronary syndrome patients undergoing percutaneous coronary intervention in Europe.
Ferrières J; Sartral M; Tcherny-Lessenot S; Belger M;
Arch Cardiovasc Dis; 2011 Feb; 104(2):104-14. PubMed ID: 21402345
[TBL] [Abstract][Full Text] [Related]
5. Contemporary use of prasugrel in clinical practice: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
Sandhu A; Seth M; Dixon S; Share D; Wohns D; Lalonde T; Moscucci M; Riba AL; Grossman M; Gurm HS
Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):293-8. PubMed ID: 23674313
[TBL] [Abstract][Full Text] [Related]
6. Impact of European Society of Cardiology and European Association for Cardiothoracic Surgery Guidelines on Myocardial Revascularization on the activity of percutaneous coronary intervention and coronary artery bypass graft surgery for stable coronary artery disease.
Yates MT; Soppa GK; Valencia O; Jones S; Firoozi S; Jahangiri M
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):606-10. PubMed ID: 23402690
[TBL] [Abstract][Full Text] [Related]
7. Observational study of adherence to European clinical practice guidelines for the management of acute coronary syndrome in revascularized versus non-revascularized patients - the CONNECT Study.
Sabouret P; Asseman P; Dallongeville J; Dujardin JJ; Philippe F; Herrmann MA; Montalescot G;
Arch Cardiovasc Dis; 2010; 103(8-9):437-46. PubMed ID: 21074122
[TBL] [Abstract][Full Text] [Related]
8. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
Ge Z; Baber U; Claessen BE; Farhan S; Chandrasekhar J; Li SX; Sartori S; Kini AS; Rao SV; Weiss S; Henry TD; Vogel B; Sorrentino S; Faggioni M; Kapadia S; Muhlestein B; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R
Catheter Cardiovasc Interv; 2019 Feb; 93(3):E112-E119. PubMed ID: 30351514
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
[TBL] [Abstract][Full Text] [Related]
10. International data on supportive therapies at 1 year in acute coronary syndrome patients undergoing PCI: results from the APTOR study.
Bakhai A; Ferrieres J; Iñiguez A; Schmitt C; Sartral M; Belger M; Zeymer U
Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):518-25. PubMed ID: 21450649
[TBL] [Abstract][Full Text] [Related]
11. Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study.
Savonitto S; Ambrosini V; Marzocchi A; Tolaro S; Petronio AS; Galassi AR; Bongo AS; Gaglione A; Bolognese L; ;
Ital Heart J; 2005 Feb; 6(2):106-18. PubMed ID: 15819503
[TBL] [Abstract][Full Text] [Related]
12. [The European Society of Cardiology (ESC) guidelines for percutaneous coronary interventions (PCI). Three case reports].
Silber S; Richartz BM; Brilmayer M;
Herz; 2006 Dec; 31(9):836-46, 848. PubMed ID: 17180646
[TBL] [Abstract][Full Text] [Related]
13. Treatment patterns in acute coronary syndrome patients in the United Kingdom undergoing PCI.
Bakhai A; Iñiguez A; Ferrieres J; Schmitt C; Sartral M; Belger M; Zeymer U;
EuroIntervention; 2011 Mar; 6(8):992-6. PubMed ID: 21330248
[TBL] [Abstract][Full Text] [Related]
14. Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: the EURHOBOP study.
Pereira M; Araújo C; Dias P; Lunet N; Subirana I; Marrugat J; Capewell S; Bennett K; Azevedo A
Eur J Prev Cardiol; 2014 Nov; 21(11):1401-8. PubMed ID: 23787795
[TBL] [Abstract][Full Text] [Related]
15. Treatment, outcomes, costs, and quality of life of women and men with acute coronary syndromes who have undergone percutaneous coronary intervention: results from the antiplatelet therapy observational registry.
Bakhai A; Ferrières J; James S; Iñiguez A; Mohácsi A; Pavlides G; Belger M; Norrbacka K; Sartral M
Postgrad Med; 2013 Mar; 125(2):100-7. PubMed ID: 23816776
[TBL] [Abstract][Full Text] [Related]
16. Predictors of long-term use of evidence-based therapies after non-ST-segment elevation acute coronary syndrome. The S-Témoin survey.
Danchin N; Diévart F; Thébaut JF; Grenier O; Mihci E; Herrmann MA; Ferrières J
Int J Cardiol; 2009 Mar; 133(1):32-40. PubMed ID: 18375000
[TBL] [Abstract][Full Text] [Related]
17. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry.
Maggioni AP; Anker SD; Dahlström U; Filippatos G; Ponikowski P; Zannad F; Amir O; Chioncel O; Leiro MC; Drozdz J; Erglis A; Fazlibegovic E; Fonseca C; Fruhwald F; Gatzov P; Goncalvesova E; Hassanein M; Hradec J; Kavoliuniene A; Lainscak M; Logeart D; Merkely B; Metra M; Persson H; Seferovic P; Temizhan A; Tousoulis D; Tavazzi L;
Eur J Heart Fail; 2013 Oct; 15(10):1173-84. PubMed ID: 23978433
[TBL] [Abstract][Full Text] [Related]
18. Management of acute coronary syndromes in Maghreb countries: The ACCESS (ACute Coronary Events - a multinational Survey of current management Strategies) registry.
Moustaghfir A; Haddak M; Mechmeche R
Arch Cardiovasc Dis; 2012 Nov; 105(11):566-77. PubMed ID: 23177485
[TBL] [Abstract][Full Text] [Related]
19. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
[TBL] [Abstract][Full Text] [Related]
20. Management of acute coronary syndromes in developing countries: acute coronary events-a multinational survey of current management strategies.
ACCESS Investigators
Am Heart J; 2011 Nov; 162(5):852-859.e22. PubMed ID: 22093201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
